Precision BioSciences, Inc. Share Price

Precision BioSciences, Inc. Share Price

NASDAQ: DTIL | Micro Cap
$7.43
-$0.02 (-0.2%) Last updated on 30 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Precision BioSciences, Inc. Stock Performance

Open
$7.56
Prev. Close
$7.45
Circuit Range
N/A
Day Range
$7.39 - $7.70
Year Range
$3.53 - $9.55
Volume
9,166
Average Traded
$7.51

Precision BioSciences, Inc. Share Price Today

As of 30 October 2026, Precision BioSciences, Inc.'s share price is $7.43. The stock opened at $7.56, compared to its previous close of $7.45. During today's trading session, Precision BioSciences, Inc.'s share price traded between $7.39 and $7.70, with an average price of $7.55. Over the past 52 weeks, the stock has recorded a high of $9.55 and a low of $3.53. In terms of performance, Precision BioSciences, Inc.'s share price has risen by 3.77% over the last six months and is down 8.99% on a year-on-year basis.

Precision BioSciences, Inc. Share Price Chart

Line chart of the Precision BioSciences, Inc. price trend over the selected period. The price fell overall, ranging from 7.38 to 7.78, ending at 7.43.
$7.39$7.70
L
Show Current Price
H

Precision BioSciences, Inc. Stock Fundamentals & Key Indicators

Market Cap
$95.30M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-2.09
Revenue (TTM)
$34.26B
Return On Equity (TTM)
-127.64%
Profit Margin
-133.45%
Debt to Equity
0.50
Quarterly Earnings Growth YoY
-49.98%

Precision BioSciences, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Jun 2025Jun 2026
Revenue$0.01$34.20$0.02$0.00
Net Profit-$21.77$20.13-$23.52-$32.65
Net Profit Margin-217700.00%58.86%-117600.00%N/A
Income ChangeN/A192.47%-216.84%-38.82%

Precision BioSciences, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$25.10$48.73$68.70$34.26
Net Profit-$111.64-$61.32$7.17-$45.72
Net Profit Margin-444.78%-125.84%10.44%-133.45%
Income ChangeN/A45.07%111.69%-737.66%

About Precision BioSciences, Inc.

Precision BioSciences Inc clinical stage gene editing company utilizing its proprietary ARCUS platform to concurrently develop two clinical-stage in vivo gene editing therapies. The ARCUS platform is used to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion (inserting DNA into gene to cause expression/add function), elimination (removing a genome, e.g. viral DNA), and excision (removing a large portion of a defective gene by delivering two ARCUS nucleases in a single adeno-associated virus ("AAV")).

Precision BioSciences, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$6.33
$7.43
+18.50%
Sep 2026
$7.56
$6.27
-25.27%
Aug 2026
$6.96
$8.39
+20.20%
Jul 2026
$7.99
$6.98
-11.42%
Jun 2026
$6.95
$7.88
+13.14%
May 2026
$6.96
$6.96
-2.72%
Apr 2026
$5.52
$7.16
+29.95%
Mar 2026
$4.08
$5.51
+31.19%
Feb 2026
$3.92
$4.20
+6.06%
Jan 2026
$4.02
$3.96
-4.46%
Dec 2025
$5.50
$4.14
-23.59%
Nov 2025
$6.22
$5.42
-33.55%

DTIL Share Price FAQs